Washington Trust Advisors, Inc. Merus N.V. Put Options Transaction History
Washington Trust Advisors, Inc.
- $1.06 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MRUS
# of Institutions
164Shares Held
47.9MCall Options Held
123KPut Options Held
293K-
Commodore Capital LP New York, NY4.36MShares$243 Million16.96% of portfolio
-
Rtw Investments, LP New York, NY4.11MShares$229 Million2.97% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.65MShares$148 Million2.46% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.25MShares$125 Million0.24% of portfolio
-
Samlyn Capital, LLC New York, NY2.08MShares$116 Million1.66% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.56B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...